Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte-associated transmembrane protein 2 (KCT2)
- Target
- KCT2
- Molecular classification
- Other (membrane protein; specific superfamily or enzymatic class not established)
01
Overview
Keratinocyte-associated transmembrane protein 2 (KCT2), also known as Chromosome 5 open reading frame 15 (C5orf15), is a human protein coded by the C5orf15 gene. This protein is predicted to localize to cellular membranes and may be specifically enriched in keratinocytes, the predominant cell type of the epidermis, though its precise biological function remains uncharacterized and there is no strong evidence for a role in major cellular pathways or disease mechanisms to date[7][14][8][6]. C5orf15 is recognized as a protein-coding gene but is not currently classified as an established therapeutic target, nor is it associated with any known interacting drugs, biomarkers, or specific safety concerns in the therapeutic context. Research is ongoing to determine its full spectrum of biological activity.
- Other names
- C5orf15Chromosome 5 open reading frame 15HTGN29keratinocyte associated transmembrane protein 2Keratinocyte-associated gene productKCT2keratinocytes associated transmembrane protein 2
02
Biological functions
Possible involvement in membrane structure or function (exact biological roles unknown)Predicted localization in cellular membranes[7][14]
03
Disease associations
Other (limited evidence: associated with Conduct disorder and Berylliosis in databases, but no direct mechanistic disease role established)[7]
Beyond the preview
Go deeper on Keratinocyte-associated transmembrane protein 2 (KCT2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keratinocyte-associated transmembrane protein 2 (KCT2).